for use in the country.
Last week, Filipino companies signed a deal with AstraZeneca for 2.6 million doses of its vaccine, which is expected to cover more than 1 million Filipinos. But while the company claims that it has an average efficacy of 70%, questions were raised about the number and ages of participants included in the study.
He pointed out that there will also be a clinical trial in the Philippines so that would be added assurance that the vaccine would be safe for Filipinos.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Philippines Latest News, Philippines Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.